Journal
NATURE MEDICINE
Volume 17, Issue 5, Pages 544-545Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nm0511-544
Keywords
-
Ask authors/readers for more resources
Thiazolidinediones (TZDs) target peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and are widely prescribed to treat type 2 diabetes but are associated with substantial weight gain. This side effect of TZDs is now shown to be mediated via brain PPAR-gamma. These findings suggest an important role for brain PPAR-gamma in obesity and have major implications for the clinical use of TZDs (pages 623-626 and 618-622).
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available